Key result
Prior beta-blocker use is linked to increased depression and anxiety symptoms three months post-PE.
Why the study?
Beta-blockers and statins are often prescribed in pulmonary embolism patients with cardiovascular comorbidities, but their association with symptoms of depression and anxiety after PE requires investigation.
Does regular use of beta-blockers or statins prior to pulmonary embolism affect symptoms of depression and anxiety 3 months after the event?
Cohort (n=538)
No
Does regular use of beta-blockers or statins prior to pulmonary embolism affect symptoms of depression and anxiety 3 months after the event?
Prior use of beta-blockers, but not statins, is associated with increased symptoms of depression and anxiety 3 months after a pulmonary embolism.
Answers are grounded in this paper and cite their sources.
Prior beta-blocker use was associated with higher depressiveness; leaves open causality and requires prospective confirmation before practice implications.
Rationale Beta-blockers and statins are important drugs for the prevention of several cardiovascular diseases and are often prescribed in pulmonary embolism (PE) patients suffering from cardiovascular comorbidities. The present observational cohort study aims to investigate the potential association between the use of both beta-blockers and statins and the symptoms of depression and anxiety after PE. Methods and results This analysis is based on 538 patients with acute PE who were admitted to the University hospital Augsburg between the years 2017 and 2022 and participated in the ‘Lungenembolie-Augsburg (LEA)’ study. The participants were interviewed during their hospital stay and received postal questionnaires three months after discharge. Symptoms of depression and anxiety were measured using the Hospital Anxiety and Depression Scale (HADS). Multivariable linear regression models were used to evaluate the association between both regular beta-blocker and statin use prior to PE and depression and anxiety (HADS-Scores) three months after PE, respectively. While prior use of beta-blockers was significantly associated with depressiveness (β = 0.87 [0.01–1.74], p = 0.046) and anxiety (β = 0.87 [CI: 0.05–1.69], p = 0.037), statins did not show a significant association with either depression or anxiety. Conclusion This study demonstrates an association between beta-blocker use and mental well-being of PE patients, which physicians must be aware of in the treatment of these patients.
No takes yet. Share an insight, caveat, or question.
Sabljo et al. (2026) conducted a cohort in Pulmonary embolism (n=538). Beta-blocker use vs. No beta-blocker use was evaluated on Depression symptoms (HADS-D score) at 3 months (β = 0.87, 95% CI 0.01-1.74, p=0.046). Prior use of beta-blockers was associated with increased symptoms of depression and anxiety three months after pulmonary embolism, whereas statin use showed no association.
Synapse has enriched 10 related papers. Consider them for comparative context: